Article in HTML

Author(s): Prathyusha Barla1, Mangamma Kuna2, Abeda Begum Shaik3, Nikhil Deep Gunnada4

Email(s): 1kunamanga@gmail.com, 2

Address:

    Department of pharmaceutical analysis, school of pharmaceutical sciences and technologies JNTUK, Kakinada, India- 533003

Published In:   Volume - 4,      Issue - 6,     Year - 2025


Cite this article:
Prathyusha Barla, Mangamma Kuna, Abeda Begum Shaik, Nikhil Deep Gunnada. Design and Validation of a RPHPLC Method for Concurrent Determination of Haloperidol and Trihexyphenidyl in API and Combined Tablet Formulations. IJRPAS, June 2025; 4 (6): 1-5.

  View PDF

Please allow Pop-Up for this website to view PDF file.




Design and Validation of a RPHPLC Method for Concurrent Determination of Haloperidol and Trihexyphenidyl in API and Combined Tablet Formulations

        

  Prathyusha Barla, Mangamma Kuna*, Abeda Begum Shaik, Nikhil Deep Gunnada

Department of pharmaceutical analysis, school of pharmaceutical sciences and technologies JNTUK, Kakinada, India- 533003

*Correspondence: kunamanga@gmail.com, mobile no: +91 8465039394

DOI: https://doi.org/10.71431/IJRPAS.2025.4601  

Article Information

 

Abstract

Research Article

Received: 11/06/2025

Accepted: 20/06/2025

Published: 30/06/2025

 

Keywords

Haloperidol; Trihexyphenidyl; RPHPLC;

Simultaneous Estimation;

ICH guidelines

 

 

An easy to use, clear, and reliable robust reversed-phase high-pressure liquid chromatography method was established and verified for the combined analysis of Haloperidol & Trihexyphenidyl in active pharmaceutical ingredient and combination tablet formulation. The compound separation through chromatographic technique was attained using a suitable octadecylsilane column with a solvent consisting of an optimized ratio of organic and aqueous solvents, under elution using a constant solvent composition. The absorbance was monitored at a wavelength suitable for both drugs using a Ultra-violet detector. The method was validated following international conference and Harmonization guidelines, assessing parameters such as specificity, linearity, accuracy, precision, detection limit, quantification limit, robustness, and system suitability. The method demonstrated good linearity over the concentration ranges studied, with correlation coefficients close to 1. Recovery testing proved the method to be accurate, and the low %Relative standard deviation values confirmed its consistent precision. The developed approach can be reliably used for regular quality assessment of Haloperidol & Trihexyphenidyl in raw drug substance & tablet formulation.

INTRODUCTION

High pressure liquid chromatography is a sophisticated technique used to detect, separate and measure substances in a liquid mixture. It is a type of chromatography, a method used to break down mixtures into individual substances. High-pressure Liquid Chromatography is a refined analytical method derived from liquid chromatography, designed to separate and identify components within complex chemical mixtures. It is extensively used in scientific and industrial applications.[1] It is extensively used in scientific and industrial applications. It is commonly employed to examine complex samples in areas like chemistry, biology and the pharmaceutical industry. The method relies on a physical separation process where compounds are divided as they pass through a narrow column filled with stationary material, while being pushed along by a liquid (or sometimes gas) called the mobile phase.[2] This technique can provide detailed information about substances, such as their size, shape, charge, polarity (hydrophilic or hydrophobic nature), structure, & molecular weight. The High pressure liquid chromatography system is made up of several parts, including a sample injector, mobile phase, stationary phase, and a detector. Common types of detectors used in High pressure liquid chromatography include UV-visible, fluorescence, & electrochemical detectors. These detect compounds based on how much light they absorb, how they fluorescence, or the current they generate. Mass spectrometry can also be used for more detailed or complex analysis.[3]

                     High pressure liquid chromatography has a wide range of applications; In pharmaceuticals, its used to detect active ingredients, check for impurities, develop new drugs, & test biological samples. In biotechnology, it helps in studying & purifying proteins & enzymes. In forensics, it is used to identify substances found at crime scenes. The agrochemical industry uses it to check pesticide levels in crops, food, & water. In environmental analysis, High pressure liquid chromatography helps detect pollutants like metals & chemicals in air, soil, & water.[5] High pressure liquid chromatography is known for its high sensitivity, precision, & reproducibility. It is considered a gold standard for analytical methods because it delivers fast, accurate, and cost-effective results, making it one of the most reliable techniques for analyzing a wide range of substances.[4]

MATREIALS AND METHODOLOGY

MATERIALS

Haloperidol, trihexyphenidyl hydrochloride reference standards, combined tablet formulations purchased from nearby medical stores, high-purity acetonitrile, analytical grade methanol, H3PO4.[5]

Formulation of buffer solution and mobile phase for analysis

Formulation of triethylamine buffer solution:

In a volumetric flask, combine 1 liter of HPLC- grade solvent with 1ml of triethylamine to obtain a 0.1% v/v concentration. Stir the solution well. Bring the pH to the desired level, usually around 2.5 to 3.0, by adding dilute phosphoric acid. Add acid dropwise while monitoring check the pH using a standardized PH meter. Once it reaches the target value, move the solution into a 1000 mL volumetric flask (if not already in it) and make up the amount to 1 liter with water. Pass the buffer solution through a 0.45-micron membrane filter and degas by sonication (typically 5–10 minutes) before use.[6]

Making the mobile phase solution:

Mobile Phase Composition:

Methanol:0.1% Triethylamine Buffer (the pH was set to 3.0 using H3PO4) and the mixture was prepared in a 70:30 volume-to-volume ratio.[7]

Preparation Procedure:

1. Formulating the buffer (0.1% Triethylamine, pH 3.0):

Take 1 mL of Triethylamine and dilute it to 1 liter of HPLC-grade solution. Adjust the pH to 3.0 ± 0.05 using orthophosphoric acid (approximately 1–2 mL of 10% v/v solution) pass the buffer through a 0.45 micro meter membrane filter, then remove dissolved gases by sonicating it for 10 minutes.

 

 

2. Mixing the Mobile Phase:

Combine 700 milliliters of solvent-grade methanol used in HPLC procedures with 300 milliliters of the prepared buffer. Filter the final mixture pass through a 0.45 micrometer membrane. Then subject it to degassing the mobile phase using ultrasonic treatment for 10–15 minutes before use.[8]

Diluent preparation:

Accurately measure 500mL of acetonitrile and place it in a clean, and moisture free beaker. Mix 500mL of purified water with acetonitrile. Mix thoroughly using a magnetic stirrer until a homogenous solution is obtained. Ensure the diluent is passed through a 0.45- micron filter before it is utilized. Store the prepared diluent in an amber bottle at room temperature and use within a few days to avoid contamination or degradation.[9]

PREPARATION OF STANDARD STOCK SOLUTIONS:

HALOPERIDOL STANDARD STOCK SOLUTION (1000µg/mL)

Measure 10mg of haloperidol with precision and transfer it to a 100mL flask. Introduce approximately 70mL of the suitable diluent. Sonicate to dissolve completely. Adjust the final volume to 100mL with the mobile phase. Final concentration is 1000 µg/mL.

TRIHEXYPHENIDYL STANDARD STOCK SOLUTION (100µg/mL)

Accurately weigh 10mg of trihexyphenidyl (API). Transfer it to a 100mL measuring flask. Roughly 700mL of mobile phase should then be added. Sonicate to dissolve thoroughly. Top up the solution to 100mL with the previously used mobile phase. Final concentration is 1000 µg/mL.

PREPARATION OF WORKING STANDARD SOLUTION:

Withdraw 1mL of each standard stock and transfer it to a 10mL volumetric container. Dilute to volume with the mobile phase. A working standard solution was made with a final concentration of;

Haloperidol is 10 µg/mL

Trihexyphenidyl is 10 µg/mL[10]

RESULTS AND DISCUSSION

The proposed RP-HPLC method was systematically validated according to the ICH protocols. The methods performance was evaluated based on system suitability, linearity, precision, accuracy, sensitivity (LOD & LOQ), and robustness.

SYSTEM PERFORMANCE CHECK

To validate the consistency & reliability of the chromatographic system, system suitability tests were conducted. A total of five injections of the standard were made, and the relative standard deviation of the peak areas was evaluated. The %RSD values were 1.09% for trihexyphenidyl & 0.73% for haloperidol, confirming the systems adequacy for analysis.[11]

LINEARITY

To check linearity, each analyte was tested at five different concentrations. Trihexyphenidyl showed a strong linear response within the concentration range of 15 to 75 microgram per milliliter, the method showed a correlation coefficient of 0.999 and a regression equation of y= 12066x + 13756. Similarly, haloperidol exhibited linearity from 37.5-187.5 µg/mL, also with an r2 value of 0.999, & its regression equation was y=18768x + 33265. These findings demonstrate that the method produces a proportional response across the studied concentration ranges.

SENSITIVITY (LOD & LOQ)

The methods sensitivity was evaluated by calculating the LOD & LOQ. Trihexyphenidyl had an LOD of 0.8 µg/mL, while the LOD for haloperidol was 6.9 µg/mL. The respective LOQ values were found to be 2.6 µg/mL and 21.1 µg/mL. These results demonstrate that the method can accurately detect and measure low concentrations levels of both drugs.

PRECISION

INTRA-ASSAY PRECISION

Intra-assay precision was assessed through examination of the standard solution 5 times under identical conditions. The %RSD values were 0.42% for trihexyphenidyl and 0.18% for haloperidol, confirming good precision.

INTERMEDIATE PRECISION

Intermediate precision, which evaluated the methods reproducibility under varied conditions (such as different days), yielded %RSD values of 0.37% for trihexyphenidyl and 0.13% for haloperidol. These findings demonstrate that the method consistently produces reliable and reproducible results.

ACCURACY

To verify accuracy, recovery experiments were conducted at 3 concentration levels; At levels of 50%, 100%, & 150%, known quantities of the standard drugs were spiked into previously analyzed samples and the samples were reanalyzed. The percentage recoveries were within acceptable ICH limits for both analytes, confirming the methods accuracy in estimating drug content in combined tablet formulations.

DURABILITY (ROBUSTNESS)

To assess the robustness of the RP-HPLC method, small deliberate changes were made to the parameters like the flow rate and mobile phase composition. These changes did not significantly affect the peak area, retention time, or other system suitability parameters, showing that the method remains consistent and dependable under slight operational deviations. The findings validated that the method remains stable and reliable for regular analytical use.[12]

FORMULATION ASSAY

To determine the concentration of the drug within the market solid formulation, the assay was performed using the developed method. Both the sample and standard solution concentrations were determined using a conventional calculation formula. Purity analysis of the tablet dosage form revealed 99.6% for trihexyphenidyl and 99.7% for haloperidol. These values reflect the accuracy and efficiency of the method in estimating the active pharmaceutical ingredients in commercial products.

%ASSAY=

(Area of sample / Area of standard) x (Concentration of standard / Concentration of sample) x (Purity of standard)[13]

CONCLUSION

A robust, dependable and exact reverse-phase HPLC method was successfully formulated and confirmed for the combined analysis of haloperidol and trihexyphenidyl in both active drug substance (API) form and combined tablet dosage formulation. The method demonstrated excellent validation parameters, in compliance with ICH protocols. The retention times for both analytes were well-resolved, unaffected by excipients or breakdown compounds, confirming the methods specificity. The proposed method is therefore appropriate for regular quality testing & stability examination of haloperidol and trihexyphenidyl within medicinal preparations.

ACKNOWLEDGMENT

I would like to express my sincere gratitude to Dr. k. Mangamma Assistant professor Department of Pharmaceutical Analysis, Jawaharlal Technological University Kakinada. For her valuable guidance, encouragement, and support throughout the work.

REFERENCES

1.    Ahmed R. High-performance liquid chromatography (HPLC): Principles, applications, versatility, efficiency, innovation and comparative analysis in modern analytical chemistry and in pharmaceutical sciences. In: Modern Methods of Pharmaceutical Analysis. 2nd ed. Vol. II. 2024.

2.    Coskun O. Separation techniques: Chromatography. North Clin Istanb. 2016;3(2):156–60.

3.    Merck. A Practical Guide to High Performance Liquid Chromatography. Darmstadt: Merck KGaA.

4.    Debnath S, Das M, Mondal S, Sarkar BK, Babu G. Advances in chromatography: contemporary techniques and applications. Essential Chem. 2023;1(1).

5.    Jain AK, Dubey BK, Basedia D, Dhakar S, Ahirwar M, Jain A. Comparison of RP-HPLC and UV spectrophotometric methods for estimation of haloperidol in pure and pharmaceutical formulation. J Drug Deliv Ther. 2018;8(6):287–91.

6.    Meyer VR. Practical High-Performance Liquid Chromatography. 4th ed. New York: Wiley; 2006.

7.    Khan IU, Razzaq SN, Mariam I, Ashfaq M, Razzaq SS. Stability-indicating RP-HPLC method for simultaneous determination of gatifloxacin and flurbiprofen in binary combination. Pak J Pharm Sci. 2021;37(1).

8.    Tirumalai R. Validation of alternative microbiological methods. PDA Pharm Sci Technol. 2005;31(1).

9.    Fish Products Division. Manual of Methods of Analysis of Foods: Fish and Fish Products. New Delhi: FSSAI.

10.    Loverock B, Simon B, Burgenson A, et al. A recombinant factor C procedure for the detection of gram-negative bacterial endotoxin. Pharm Forum. 2009;35(3).

11.    Mestareehi AH. Optimized and validated stability-indicating RP-HPLC method for comprehensive profiling of process-related impurities and stress-induced degradation products in rivaroxaban (Xarelto). Int J Mol Sci. 2023;26(2).

12.    Shaalan RA, Belal TS, El Yazbi FA, Elonsy SM. Validated HPTLC methods for determination of some selected antihypertensive mixtures in their combined dosage forms. Bull Fac Pharm Cairo Univ. 2014;52(1):1–9.

13.    Wate SP, Borkar AA. Simultaneous spectrophotometric estimation of haloperidol and trihexyphenidyl in tablets. Indian J Pharm Sci. 2010;72(2):263–5.



Related Images:

Recomonded Articles:

Author(s): Magendran Rajendiran1*, Muruganand R2, Abhisek Kumar Sinha2, Mohamed Raashith M S2, Jasitha Begam M2, Usharani G2, Dhivyari D2, Deepika T2

DOI: https://doi.org/10.71431/IJRPAS.2025.4413         Access: Open Access Read More

Author(s): Patil Aachal*; Nusrat Khan

DOI:         Access: Open Access Read More

Author(s): Kazi Kaif Aarefoddin; Mohommad Altamash*; Abdullah Danish

DOI: https://doi.org/10.71431/IJRPAS.2025.4313         Access: Open Access Read More

Author(s): Hasanen Pinjari; Rehan Deshmukh; Khan Faizan; Dr. Gulam Javed.

DOI:         Access: Open Access Read More

Author(s): Kalyani P.Patil; Damini M.Patil; Sunila A.Patil; Sunil.P.Pawar.

DOI:         Access: Open Access Read More

Author(s): S. Sathya, Karthiga. D, Lokesh. S, Sabari Manikandan, V. R. Rajeswari

DOI: https://doi.org/10.71431/IJRPAS.2025.4105         Access: Open Access Read More

Author(s): Mr. Shrinivas Kapale; Mr. Gopal Lohiya; Dr.Kranti Satpute

DOI:         Access: Open Access Read More

Author(s): Girisha Chaudhari;Sofiya Morris; Dr. Ashish Jain

DOI:         Access: Open Access Read More

Author(s): Mohammad Zaid*; Prof. Imran Kalam; Dr. Quazi Majaz

DOI:         Access: Open Access Read More

Author(s): Shaikh Aklakh Gafar1*; Dr. M.H.G Dehghan1;Khan Juber Kadir2

DOI:         Access: Open Access Read More

Author(s): Shaikh Aminoddin Raisoddin; Shifa Maniya; Sayeeda Begum; Naziya Shaikh.

DOI:         Access: Open Access Read More

Author(s): Baburao Mohite; Manisha Mane; Sarika Suryavanshi; Shrirang Kharmate; Pranali Patil; Anand Gadad.

DOI:         Access: Open Access Read More

Author(s): Devadatta Pandurang Hatim; Sachinkumar V. Patil; Sachin Mali

DOI:         Access: Open Access Read More

Author(s): Momin Zain; Shaikh Arbaz; Shaikh Adnan; Rehan Deshmukh

DOI:         Access: Open Access Read More

Author(s): Quazi Kamil Hafiz Anees Ahemad; Dr. Majaz Quazi; Quazi Wasil; Dr. G. J. Khan

DOI:         Access: Open Access Read More

Author(s): Museb shaikh Mukhtar; Khalifa Mahmadasif Y; Pathan Ayyaj Magbul; Shaikh Faisal; Shaikh Aman; MD Moiz, Shaikh Arbaj.

DOI:         Access: Open Access Read More

Author(s): Nilesh R. Suryawanshi; Karan. A. Patil; Nikhil. J. Rajput; H. P. Suryawanshi; R. A. Ahirrao; J. I. Pinjari

DOI:         Access: Open Access Read More

Author(s): Lubna Patel; Umama Saudagar

DOI:         Access: Open Access Read More

Author(s): Omkar Dhembare; Ashish Jain; Sofiya Moris

DOI:         Access: Open Access Read More